May 13 (Reuters) - Spanish pharmaceutical company
Almirall ALM.MC on Monday reiterated its profitability targets
for the full-year and said it is seeking acquisition targets,
even though its costs weighed on net profit in the first
quarter.
The company said its net profit fell 4% in the quarter to
7.4 million euros ($7.97 million) on higher costs, while
earnings before interest, taxes, depreciation and amortisation
rose 1.4% to 52.5 million euros.
Almirall said it is on track to meet its 2024 full-year
target of EBITDA of between 175 and 190 million euros, up from
174 million euros in 2023 and high-single digit net sales
growth. It added it seeks "new inorganic growth opportunities."
($1 = 0.9282 euros)
(Reporting by Matteo Allievi, editing by Inti Landauro and
Louise Heavens)
((matteo.allievi@thomsonreuters.com;))